Heart Failure, Left-sidedNCT06200246
Cardio-vascular Energy Transfer and Ventriculo-arterial Coupling in Heart Failure
An observational study of Heart Failure, Left-sided, run by St. Olavs Hospital at 1 site in Norway.
Trial summary
The goal of this pilot study is to investigate energy transfer fram the ventricle to the arteries in patients with heart failure, primary by investigating the total power. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Heart Failure, Left-sided
- How many people
- 30 participants
- Where
- 1 siteNorway
- Study dates
- 1 Oct 2022to 1 Jul 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Child, Adult, Older adult
Study population: The study population comprises individuals experiencing decompensated heart failure within the first three days of hospital admission. It includes both newly diagnosed cases and individuals with a pre-existing heart failure diagnosis. The population is diverse, both regarding gender and etiology.
Who may be able to join
- Acute left ventricular failure due to:
- Myocardial ischemia
- Cardiomyopathy
- Myocarditis Sinus rhythm Age >18 years
Who cannot join
- Cardiogenic shock Mechanical circulatory support Respiratory treatment Inotropic infusions Tachyarrhythmias Lack of capacity to consent
Trial locations and contacts
1 site in 1 country.
About this study
The goal of this pilot study is to investigate energy transfer fram the ventricle to the arteries in patients with heart failure, primary by investigating the total power.
- Conditions
- Heart Failure, Left-sided
- Medical subject headings
- Heart Failure
What is being measured
The primary outcome is the main question the study is designed to answer.
Cardio vascular energy transfer in heart failure patients.
The investigators are investigating cardio vascular energy transfer in heart failure patients by calculating total power.
Measured: During first 1-3 days after admission to hospital because of decompensated heart failure.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Jan 2024
- Study start1 Oct 2022
- Primary completion1 Jul 2023
- Study completion1 Jul 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Heart Failure, Left-sidedStudies of the same condition, open and under way.
- More trials run by St. Olavs HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Prospective
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- St. Olavs Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- National Taiwan Normal University
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06200246
- Sponsor's protocol ID
- 480738
- Status last verified
- Sep 2026
- First submitted
- 28 Dec 2023
- Last updated
- 11 Sep 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cardio-vascular Energy Transfer and Ventriculo-arterial Coupling in Heart Failure
- ClinicalTrials.gov ID
- NCT06200246
- Acronym / sponsor ID
- 480738
- Conditions
- Heart Failure, Left-sided
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- St. Olavs HospitalUniversity, hospital or other
- Collaborators
- National Taiwan Normal University
- Study start
- 1 Oct 2022 (actual)
- Primary completion
- 1 Jul 2023 (actual)
- Study completion
- 1 Jul 2023 (actual)
- First posted
- 10 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this pilot study is to investigate energy transfer fram the ventricle to the arteries in patients with heart failure, primary by investigating the total power.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Prospective
Who may qualify
- Sex
- All
- Age groups
- Child, Adult, Older adult
- Study population
- The study population comprises individuals experiencing decompensated heart failure within the first three days of hospital admission. It includes both newly diagnosed cases and individuals with a pre-existing heart failure diagnosis. The population is diverse, both regarding gender and etiology.
Key inclusion criteria (4 listed)
- Myocardial ischemia
- Cardiomyopathy
- Myocarditis Sinus rhythm Age >18 years
Key exclusion criteria (1 listed)
- Cardiogenic shock Mechanical circulatory support Respiratory treatment Inotropic infusions Tachyarrhythmias Lack of capacity to consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Cardio vascular energy transfer in heart failure patients.
Time frame: During first 1-3 days after admission to hospital because of decompensated heart failure.
The investigators are investigating cardio vascular energy transfer in heart failure patients by calculating total power.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Sep 2026.
Related trials for Heart Failure, Left-sided
Not yet recruitingPhase 2
The CARDIOPROTECT Trial
Diffuse Large B-cell Lymphoma (DLBCL), Cardiotoxicity
Active, not recruiting
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Cardiovascular Diseases, Heart Diseases
Recruiting
LEFT ATRIAL MONITORING IN PATIENTS BEFORE AND AFTER MITRAL SURGERY - LAMBDA STUDY
Mitral Regurgitation, Mitral Valve Disease
RecruitingObservational study
dPmax for Predicting Right Ventricular Failure After Left Ventricular Assist Device Implantation
Ventricular Dysfunction, Right
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Heart Failure, Heart Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Heart Failure, Left-sided, run by St. Olavs Hospital at 1 site in Norway.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Cardio vascular energy transfer in heart failure patients. (time frame: During first 1-3 days after admission to hospital because of decompensated heart failure.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2026.